Download
the full report "AIDS Blood Scandals: What China Can Learn
From the World's Mistakes"(pdf)
China
Must Address Blood Safety, Compensate HIV Victims
(New York, September 6, 2007)—China needs urgent international
assistance to upgrade the safety of its blood supply, and should
establish a national fund to compensate people infected with HIV
through blood transfusions, Asia Catalyst said today.
Seven years since the exposure of mass infections of HIV-AIDS in
central Henan province through blood sales, the Chinese government's
system to ensure the safety of its national blood supply remains
dangerously inadequate, while thousands of those living with HIV/AIDS
are impoverished due to lack of a national compensation system, said
Sara (Meg) Davis, director of Asia Catalyst and co-author of the
38-page report, AIDS Blood Scandals: What China Can Learn From the
World's Mistakes. The report, simultaneously released in English and
Chinese, examines how the U.S, Canada, France and Japan handled similar
outbreaks of HIV transmitted through blood transfusions.
“China is not alone,” said Davis. “Most developed countries have dealt
with similar AIDS blood scandals, and they should step forward to offer
assistance to China.”
In the 1980s and early 1990s, thousands of people in the U.S., Japan,
France and Canada contracted HIV/AIDS through contaminated blood
supplies. Most governments were slow to respond. While many victims
took their cases to courts, some died before winning their cases, and
many lost a large part of their recoveries to attorneys. Court cases
proved to be costly and ineffective for both victims and governments.
“Most countries eventually did three things that solved the problem,”
said Evan Anderson, research consultant for Asia Catalyst and co-author
of the report. “They held investigations, established national
compensation funds for victims, and centralized control of the blood
supply.”
In the 1990s, hundreds of thousands of Chinese villagers were infected
with HIV through state-run for-profit blood collection centers. As a
result, hospital patients have been infected with HIV through
transfusions of contaminated blood and blood products.
Despite ongoing efforts to crack down on illegal blood sales, Chinese
health officials admit that the blood supply is not yet safe. China’s
blood supply is regulated by a complicated array of national and local
agencies. Though the government has outlawed underground blood sales,
these persist in many regions. Blood donations are not always tracked
and computerized at a central level, making it possible for untested
blood to slip into the national supply.
“The demand for blood and blood products is growing in China, and
supply is short,” said Davis. “This creates an economic incentive for
hospitals to rely on illegal, untested blood donations, and that fuels
the spread of AIDS.”
The report documents the mixed success that Chinese people infected
with HIV through blood transfusions have had in the courts. In some
regions, victims have won big settlements, but have not always been
able to collect. In regions such as Henan province, where HIV infection
was widespread, courts have closed their doors and refused to hear any
HIV-related cases. The report explains how in most other countries, a
national compensation fund has proved to be a cost-effective and fair
solution to the problem.
“While the worst of the catastrophe is in the past, the threat to our
global future is real,” said Anderson. “China needs international
assistance to address its blood safety. The AIDS epidemic has never
respected national boundaries.”
Asia Catalyst is a New York-based nonprofit that partners with civil
society advocates in Asia to inspire, create and launch innovative,
self-sustaining programs and organizations that advance human rights,
social justice, and environmental protection.
